Uneingeschränkter Zugang

Perfluorooctanoic acid affects mouse brain and liver tissue through oxidative stress

Burcu Ünlü Endirlik

Burcu Ünlü Endirlik

  • Erciyes University Faculty of Pharmacy, Department of Pharmaceutical ToxicologyKayseri, Turkey
  • Hacettepe University Faculty of Pharmacy, Department of Pharmaceutical ToxicologyAnkara, Turkey
Suche nach diesem Autor auf
Sciendo|Google Scholar
Endirlik, Burcu Ünlü
, 
Ayşe Eken

Ayşe Eken

Erciyes University Faculty of Pharmacy, Department of Pharmaceutical ToxicologyKayseri, Turkey
Suche nach diesem Autor auf
Sciendo|Google Scholar
Eken, Ayşe
, 
Hande Canpınar

Hande Canpınar

Hacettepe University Cancer Institute, Department of Basic OncologyAnkara, Turkey
Suche nach diesem Autor auf
Sciendo|Google Scholar
Canpınar, Hande
, 
Figen Öztürk

Figen Öztürk

Erciyes University Faculty of Medicine, Department of PathologyKayseri, Turkey
Suche nach diesem Autor auf
Sciendo|Google Scholar
Öztürk, Figen
 und 
Aylin Gürbay

Aylin Gürbay

Hacettepe University Faculty of Pharmacy, Department of Pharmaceutical ToxicologyAnkara, Turkey
Orcid-Profil
Suche nach diesem Autor auf
Sciendo|Google Scholar
Gürbay, Aylin
  
07. Juli 2022
Perfluorooctanoic acid affects mouse brain and liver tissue through oxidative stress's Cover Image
Über diesen Artikel
Vorheriger Artikel
Nächster Artikel
Zitieren
COVER HERUNTERLADEN
Artikel-Kategorie: Original article
Online veröffentlicht: 07. Juli 2022
Seitenbereich: 148 - 157
Eingereicht: 01. Feb. 2022
Akzeptiert: 01. Apr. 2022
DOI: https://doi.org/10.2478/aiht-2022-73-3629
Schlüsselwörter
© 2022 Burcu Ünlü Endirlik, Ayşe Eken, Hande Canpınar, Figen Öztürk, and Aylin Gürbay, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1

Histopathological changes in mouse brain tissue stained with hematoxylin and eosin (200× magnification). A – control; B – PFOA dose of 15 mg/kg bw; C – PFOA dose of 30 mg/kg bw; D – taurine dose of 100 mg/kg bw; E – taurine+PFOA dose of 30 mg/kg bw; F – corn oil; G – CoQ10 dose of 50 mg/kg bw; H – CoQ10+PFOA dose of 30 mg/kg bw
Histopathological changes in mouse brain tissue stained with hematoxylin and eosin (200× magnification). A – control; B – PFOA dose of 15 mg/kg bw; C – PFOA dose of 30 mg/kg bw; D – taurine dose of 100 mg/kg bw; E – taurine+PFOA dose of 30 mg/kg bw; F – corn oil; G – CoQ10 dose of 50 mg/kg bw; H – CoQ10+PFOA dose of 30 mg/kg bw

Figure 2

Histopathological changes in mouse liver tissue stained with hematoxylin and eosin (200× magnification). A – control; B – PFOA dose of 15 mg/kg bw; C – PFOA dose of 30 mg/kg bw; D – taurine dose of 100 mg/kg bw; E – taurine+PFOA dose of 30 mg/kg bw; F – corn oil; G – CoQ10 dose of 50 mg/kg bw; H – CoQ10+PFOA dose of 30 mg/kg bw. Arrows: CV – central vein; H – hepatocellular hypertrophy; E – eosinophilic cytoplasm; B – balloon degeneration; FN – focal necrosis; N – necrosis; A – acidophilic cytoplasm
Histopathological changes in mouse liver tissue stained with hematoxylin and eosin (200× magnification). A – control; B – PFOA dose of 15 mg/kg bw; C – PFOA dose of 30 mg/kg bw; D – taurine dose of 100 mg/kg bw; E – taurine+PFOA dose of 30 mg/kg bw; F – corn oil; G – CoQ10 dose of 50 mg/kg bw; H – CoQ10+PFOA dose of 30 mg/kg bw. Arrows: CV – central vein; H – hepatocellular hypertrophy; E – eosinophilic cytoplasm; B – balloon degeneration; FN – focal necrosis; N – necrosis; A – acidophilic cytoplasm

Figure 3

Total MDA and GSH levels in brain and liver tissues of mice treated with PFOA, taurine, and CoQ10 (data are expressed as medians and interquartile ranges, n=6 for water and corn oil groups; n=7 for treated groups). ap<0.01 and fp<0.05 relative to control; bp<0.01 and gp<0.05 relative to taurine; cp<0.01 relative to PFOA (30 mg/kg); dp<0.05 and hp<0.01 relative to corn oil; ep<0.05 and ip<0.01 relative to CoQ10
Total MDA and GSH levels in brain and liver tissues of mice treated with PFOA, taurine, and CoQ10 (data are expressed as medians and interquartile ranges, n=6 for water and corn oil groups; n=7 for treated groups). ap<0.01 and fp<0.05 relative to control; bp<0.01 and gp<0.05 relative to taurine; cp<0.01 relative to PFOA (30 mg/kg); dp<0.05 and hp<0.01 relative to corn oil; ep<0.05 and ip<0.01 relative to CoQ10

Figure 4

Antioxidant enzyme activity in brain and liver tissues of mice treated with PFOA, taurine, and CoQ10. (data are expressed as medians and interquartile ranges, n=6 for water and corn oil groups; n=7 for treated groups). ap<0.01 and gp<0.05 relative to PFOA (30 mg/kg); bp<0.01 and fp<0.05 relative to corn oil; cp<0.01 relative to CoQ10; dp<0.01 relative to control; ep<0.05 and hp<0.01 relative to taurine
Antioxidant enzyme activity in brain and liver tissues of mice treated with PFOA, taurine, and CoQ10. (data are expressed as medians and interquartile ranges, n=6 for water and corn oil groups; n=7 for treated groups). ap<0.01 and gp<0.05 relative to PFOA (30 mg/kg); bp<0.01 and fp<0.05 relative to corn oil; cp<0.01 relative to CoQ10; dp<0.01 relative to control; ep<0.05 and hp<0.01 relative to taurine

Figure 5

Distribution of liver cells by cycle in mice treated with, PFOA, taurine, and CoQ10 (data are expressed as medians, n=3). ap<0.05 relative to the PFOA (30 mg/kg) group
Distribution of liver cells by cycle in mice treated with, PFOA, taurine, and CoQ10 (data are expressed as medians, n=3). ap<0.05 relative to the PFOA (30 mg/kg) group

Body weight and relative brain and liver weight changes in mice treated with oral PFOA, CoQ10, and taurine

Groups Body weight change from baseline (%) Relative brain weight (g/100 g) Relative liver weight (g/100 g)
Control (water) 3.03 (-6.43–8.14) 1.25 (1.19–1.36) 5.39 (5.00–5.82)
PFOA (15 mg/kg) -11.76a (-14.71–8.33) 1.50 (1.30–1.62) 15.71d (14.67–15.91)
PFOA (30 mg/kg) -21.21a (-28.57–0) 1.51a (1.27–1.65) 15.79d (15.00–17.44)
Taurine -3.23 (-10.81–2.56) 1.28 (1.18–1.45) 5.09 (5.03–5.59)
Taurine + PFOA -13.33 (-16.67–3.23) 1.46 (1.32–1.54) 16.00d,e (15.71–16.40)
Corn oil -4.37 (-12.42–2.03) 1.33 (1.19–1.48) 5.47 (4.58–6.23)
CoQ10 -7.89 (-8.33–0) 1.30 (1.24–1.36) 5.15 (5.15–5.37)
CoQ10 + PFOA -17.65b,c (-22.86–9.38) 1.37 (1.36–1.56) 15.86f,g (13.09–17.04)
Sprachen:
Englisch, Croatian, Slovenian
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Vorklinische Medizin, Grundlagenmedizin, Vorklinische Medizin, Grundlagenmedizin, andere
Zeitschrift RSS Feed